Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUROSUMAB vs BUTORPHANOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUROSUMAB vs BUTORPHANOL: Safety Overview

Metric BUROSUMAB BUTORPHANOL
Total FAERS Reports 674 462
Deaths Reported 6 10
Death Rate 0.9% 2.2%
Hospitalizations 111 24
Average Patient Age 37.3 yrs 53.9 yrs
% Female Patients 50.0% 79.2%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Kyowa Kirin, Inc. Hikma Pharmaceuticals USA Inc.
Route SUBCUTANEOUS NASAL
Marketing Status N/A Discontinued